

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors. Among its major competitors, Threshold Pharmaceuticals is ranked in 11th place for NPS while Merrimack Pharmaceuticals is 1st, and Aimmune Therapeutics is 2nd.